smart pharmaceutical (Cayman) Co., Ltd.

Smart Pharmaceutical(Cayman) Co., Ltd. was established in December 2019 with a registered capital of USD $35 million. The Company is a global research and development (R&D) oriented innovative bio-pharmaceutical company, focusing on the R&D and manufacturing of macro-molecular oral formulations and insoluble small-molecule formulations with high technical barriers. Smart Pharmaceutical views formulation innovation as its driving force and core competency. The Company uses advanced drug delivery system (DDS) to develop patented brand new drugs to improve drug clinical efficacy, in order to help patients relieve their pain and improve their quality of life. At present, our pipeline targets many areas of chronic diseases, such as cardiovascular and cerebrovascular diseases, oncology, mental illness, diabetes, gastrointestinal tract, pain and infections. Our market is mainly in Europe, the United States, Japan and Greater China. Our R&D team consists of scientists and engineers from the United States, Canada, India and China. Several core members have worked in the world’s top 50 pharmaceutical companies and have a great deal of experience in R&D, management, manufacturing, clinical and drug registration.